The Journal of Clinical Endocrinology & Metabolism,
Journal Year:
2021,
Volume and Issue:
106(9), P. e3519 - e3532
Published: May 17, 2021
Abstract
Context
Polycystic
ovary
syndrome
(PCOS),
a
highly
prevalent
endocrine
disorder
characterized
by
hyperandrogenism,
is
the
leading
cause
of
anovulatory
infertility.
Objective
This
proof-of-concept
study
evaluated
clinical
efficacy
and
safety
neurokinin
3
(NK3)
receptor
antagonist
fezolinetant
in
PCOS.
Methods
was
phase
2a,
randomized,
double-blind,
placebo-controlled,
multicenter
(EudraCT
2014-004409-34).
The
conducted
at
5
European
centers.
Women
with
PCOS
participated
study.
Interventions
included
60
or
180
mg/day
placebo
for
12
weeks.
primary
end
point
change
total
testosterone.
Gonadotropins,
ovarian
hormones,
tolerability
were
also
assessed.
Results
Seventy-three
women
randomly
assigned,
64
participants
completed
Adjusted
mean
(SE)
changes
testosterone
from
baseline
to
week
−0.80
(0.13)
−0.39
(0.12)
nmol/L
vs
−0.05
(0.10)
(P
<
.001
P
.05,
respectively).
luteinizing
hormone
(LH)
mg/d
−10.17
(1.28)
−8.21
(1.18)
−3.16
(1.04)
IU/L
=
.002);
corresponding
follicle-stimulating
(FSH)
−1.46
(0.32)
−0.92
(0.30)
−0.57
(0.26)
.03
.38),
underpinning
dose-dependent
decrease
LH-to-FSH
ratio
.001).
Circulating
levels
progesterone
estradiol
did
not
significantly
>
.10).
Fezolinetant
well
tolerated.
Conclusion
had
sustained
effect
suppress
hyperandrogenism
reduce
International Journal of Women s Health,
Journal Year:
2022,
Volume and Issue:
Volume 14, P. 91 - 105
Published: Feb. 1, 2022
Polycystic
ovary
syndrome
(PCOS)
is
one
of
the
most
common
endocrine
diseases
causing
infertility
in
women
childbearing
age.
It
characterized
by
hyperandrogenemia
(HA),
chronic
anovulation,
and
polycystic
morphology
(PCOM).
Most
with
PCOS
have
metabolic
abnormalities.
Sex
hormone-binding
globulin
(SHBG),
a
transport
carrier
that
binds
estrogen
androgens
regulates
their
biological
activity,
usually
used
as
an
indicator
hyperandrogenism
PCOS.
Low
serum
SHBG
levels
are
considered
biomarker
abnormalities
associated
insulin
resistance
(IR),
HA,
abnormal
glucose
lipid
metabolism
patients.
also
related
to
long-term
prognosis
PCOS,
whereas
gene
polymorphism
risk.
In
addition,
administration
metformin
(MET),
glucagon-like
peptide-1
receptor
agonists
(GLP-1
RAs),
thiazolidinediones
(TZDs),
compound
oral
contraceptives
(COCs),
well
nutrient
supplements
such
inositol
(MI),
vitamin
D,
synbiotics
can
regulate
ameliorate
complications
improve
prognosis.
This
review
focuses
on
interaction
between
various
regulation
drugs
nutrients
its
therapeutic
effects
Pharmaceuticals,
Journal Year:
2021,
Volume and Issue:
14(1), P. 42 - 42
Published: Jan. 8, 2021
Metformin
(MF),
a
first-line
drug
to
treat
type
2
diabetes
mellitus
(T2DM),
alone
and
in
combination
with
other
drugs,
restores
the
ovarian
function
women
polycystic
ovary
syndrome
(PCOS)
improves
fetal
development,
pregnancy
outcomes
offspring
health
gestational
(GDM)
T2DM.
MF
treatment
is
demonstrated
improve
efficiency
of
vitro
fertilization
considered
supplementary
assisted
reproductive
technologies.
administration
shows
positive
effect
on
steroidogenesis
spermatogenesis
men
metabolic
disorders,
thus
indicates
prospective
use
for
improvement
male
functions
fertility.
lacks
teratogenic
effects
has
newborns.
The
review
focused
therapy
restoration
female
endocrine
disorders.
mechanisms
action
are
discussed,
including
normalization
hormonal
status
PCOS,
GDM,
T2DM
functional
activity
regulation
gonadal
axis.
World Journal of Diabetes,
Journal Year:
2022,
Volume and Issue:
13(1), P. 5 - 26
Published: Jan. 11, 2022
Polycystic
ovary
syndrome
(PCOS)
often
coexists
with
a
wide
spectrum
of
dysglycemic
conditions,
ranging
from
impaired
glucose
tolerance
to
type
2
diabetes
mellitus
(T2D),
which
occur
greater
extent
compared
healthy
body
mass
index-matched
women.
This
concurrence
disorders
is
mainly
attributed
common
pathogenetic
pathways
linking
the
two
entities,
such
as
insulin
resistance.
However,
due
methodological
flaws
in
available
studies
and
multifaceted
nature
syndrome,
there
has
been
substantial
controversy
exact
association
between
T2D
PCOS
not
yet
elucidated.
The
aim
this
review
present
best
evidence
regarding
epidemiology
dysglycemia
PCOS,
unique
pathophysiological
mechanisms
underlying
progression
dysglycemia,
most
appropriate
methods
for
assessing
glycemic
status
risk
factors
development
population,
well
after
transition
menopause.
Proposals
application
holistic
approach
enable
optimal
management
are
also
provided.
Specifically,
adoption
lifestyle
adherence
improved
dietary
patterns,
Mediterranean
diet,
avoidance
consumption
endocrine-disrupting
foods
beverages,
regular
exercise,
effect
certain
medications,
metformin
glucagon-like
peptide
1
receptor
agonists,
discussed.
Furthermore,
maintenance
weight
highlighted
key
factor
achievement
significant
reduction
women
PCOS.
Reproductive Biology and Endocrinology,
Journal Year:
2022,
Volume and Issue:
20(1)
Published: Jan. 10, 2022
Abstract
As
a
common
endocrinopathy
of
reproductive-aged
women,
polycystic
ovary
syndrome
(PCOS)
is
characterized
by
hyperandrogenism,
oligo-anovulation
and
ovarian
morphology.
It
linked
with
insulin
resistance
through
preferential
abdominal
fat
accumulation
that
worsened
obesity.
Over
the
past
two
millennia,
menstrual
irregularity,
male-type
habitus
sub-infertility
have
been
described
in
women
confirm
these
clinical
features
PCOS
were
antiquity.
Recent
findings
normal-weight
hyperandrogenic
show
exaggerated
lipid
subcutaneous
(SC)
stem
cells
during
development
to
adipocytes
vitro
occurs
combination
reduced
sensitivity
highly-lipolytic
intra-abdominal
vivo.
This
phenotype
may
be
an
evolutionary
metabolic
adaptation
balance
energy
storage
glucose
availability
fatty
acid
oxidation
for
optimal
use
reproduction.
review
integrates
fundamental
endocrine-metabolic
changes
healthy,
similar
PCOS-like
traits
present
animal
models
which
tissue
differentiation
completed
fetal
life
as
humans
support
concept
has
ancestral
developmental
origins.
BMC Medicine,
Journal Year:
2022,
Volume and Issue:
20(1)
Published: Feb. 10, 2022
Abstract
Background
The
comorbidity
between
polycystic
ovary
syndrome
(PCOS)
and
obesity
has
long
been
observed
in
clinical
settings,
but
their
shared
genetic
basis
remains
unclear.
Methods
Leveraging
summary
statistics
of
large-scale
GWAS(s)
conducted
European-ancestry
populations
on
body
mass
index
(adult
BMI,
N
female
=434,794;
childhood
=39,620),
waist-to-hip
ratio
(WHR,
=381,152),
WHR
adjusted
for
BMI
(WHR
adj
=379,501),
PCOS
(
case
=10,074,
control
=103,164),
we
performed
a
genome-wide
cross-trait
analysis
to
quantify
overall
local
correlation,
identify
loci,
infer
causal
relationship.
Results
We
found
positive
correlations
adult
r
g
=0.47,
P
=2.19×10
−16
),
=0.31,
=6.72×10
−5
=0.32,
=1.34×10
−10
all
withstanding
Bonferroni
correction.
A
suggestive
significant
correlation
was
=0.09,
=0.04).
Partitioning
the
whole
genome
into
1703
nearly
independent
regions,
at
chromosome
18:
57630483–59020751.
identified
16
loci
underlying
obesity-related
traits
via
meta-analysis
including
9
PCOS:
5
loci;
4
loci),
6
PCOS,
PCOS.
Mendelian
randomization
(MR)
supported
roles
both
(OR=2.92,
95%
CI=2.33–3.67)
(OR=2.76,
CI=2.09–3.66)
not
(OR=1.19,
CI=0.93–1.52)
or
(OR=1.03,
CI=0.87–1.22).
Genetic
predisposition
did
seem
influence
risk
traits.
Conclusions
Our
suggests
provides
novel
insights
biological
mechanisms
these
complex
work
informs
public
health
intervention
by
confirming
important
role
weight
management
prevention.
Cells,
Journal Year:
2022,
Volume and Issue:
12(1), P. 174 - 174
Published: Dec. 31, 2022
Polycystic
ovary
syndrome
(PCOS)
is
the
most
common
heterogeneous
endocrine
disorder
among
women
of
reproductive
age.
The
pathogenesis
PCOS
remains
elusive;
however,
there
evidence
suggesting
potential
contribution
genetic
interactions
or
predispositions
combined
with
environmental
factors.
Among
these,
disrupting
chemicals
(EDCs)
have
been
proposed
to
potentially
contribute
etiology
PCOS.
Granulosa
and
theca
cells
are
known
cooperate
maintain
ovarian
function,
any
disturbance
can
lead
disorders,
such
as
This
article
provides
a
review
recent
knowledge
on
pathophysiology,
role
granulosa
in
pathogenesis,
linking
exposure
EDCs
disorders
Human Reproduction,
Journal Year:
2023,
Volume and Issue:
38(6), P. 1168 - 1182
Published: April 4, 2023
Abstract
STUDY
QUESTION
What
is
the
influence
of
body
composition
during
childhood,
adolescence,
and
adulthood,
as
well
metabolic
parameters,
on
incident
polycystic
ovary
syndrome
(PCOS)?
SUMMARY
ANSWER
Excess
fat,
even
childhood/adolescence,
suggestive
hyperinsulinaemia/insulin
resistance,
significantly
impact
risk
PCOS
in
a
linear
fashion.
WHAT
IS
KNOWN
ALREADY
Observational
Mendelian
randomization
(MR)
data
have
demonstrated
an
association
between
adulthood
overweight/obesity
development
PCOS.
However,
contribution
childhood/adolescence
to
unclear,
childhood
overweight/obesity.
DESIGN,
SIZE,
DURATION
We
conducted
systematic
review
meta-analysis
integrated
our
results
with
previously
published
review.
Two
blinded
investigators
screened
abstracts
November
2010
May
2021.
Furthermore,
we
incorporated
summary
statistics
from
genome-wide
study
(GWAS)
subjects
European
ancestry.
Adult
overweight
was
defined
BMI
≥
25
kg/m2
obesity
30
kg/m2;
Asian
subjects,
23
kg/m2.
PARTICIPANTS/MATERIALS,
SETTING,
METHODS
utilized
MR
together
allow
synthesis
genetic
observational
data.
For
review,
search
revealed
71
studies,
which
63
were
included
by
calculating
odds
ratios
(ORs)
using
random-effects
model.
two-sample
GWAS
determine
adult
size
(defined
categorically
proportions),
abnormal
parameters
(higher
fasting
serum
insulin
or
lower
sex
hormone-binding
globulin
(SHBG)
concentration)
via
inverse-variance
weighted
method.
MAIN
RESULTS
AND
THE
ROLE
OF
CHANCE
Significant
associations
shown
incidence.
From
review/meta-analysis,
women
(OR
3.80,
2.87–5.03),
4.99,
3.74–6.67),
central
2.93,
2.08–4.12)
had
increased
adolescents
and/or
obesity,
greater
than
for
adults.
MR,
every
standard
deviation
increase
(4.8
kg/m2),
2.76
(2.27–3.35).
Childhood
independent
effect
after
adjusting
(OR:
2.56,
1.57–4.20).
Genetically
determined
fat
percentage
3.05,
2.24–4.15),
whole
mass
2.53,
2.04–3.14),
6.98,
2.02–24.13),
SHBG
concentration
0.74,
0.64–0.87)
all
associated
relation.
LIMITATIONS,
REASONS
FOR
CAUTION
The
studies
cross-sectional
retrospective,
limiting
ability
causality.
limited
interrogating
only
ancestry
including
cases
classified
either
self-diagnosis
diagnostic
criteria.
WIDER
IMPLICATIONS
FINDINGS
Our
demonstrates
first
time
critical
role
excess
childhood/adolescent
adiposity
pathophysiology
results,
driven
genetically
composition,
higher
BMI,
hyperinsulinaemia,
SHBG,
clearly
favour
driving
metabolic,
but
not
reproductive,
phenotype.
Overall,
effective
weight
maintenance,
early
years,
likely
reduce
this
reproductive
endocrine
disorder.
FUNDING/COMPETING
INTEREST(S)
S.S.Z.
funded
National
Institute
Health
Care
Research
(NIHR)
Academic
Clinical
Lectureship.
U.A.
chair
NIHR
Steering
Committee
Trial—CASSANDRA-DN.
No
other
authors
declare
any
sources
funding
relevant
conflicts
interest.
that
research
absence
commercial
financial
relations
could
be
construed
potential
conflict
TRIAL
REGISTRATION
NUMBER
N/A.
Journal of Clinical Medicine,
Journal Year:
2023,
Volume and Issue:
12(4), P. 1500 - 1500
Published: Feb. 14, 2023
Polycystic
ovary
syndrome
(PCOS)
is
one
of
the
most
common
endocrine
disorders
in
women
reproductive
age.
This
not
only
impairs
female
fertility
but
also
increases
risk
obesity,
diabetes,
dyslipidemia,
cardiovascular
diseases,
psychological
and
other
health
problems.
Additionality,
because
high
clinical
heterogeneity,
current
pathogenesis
PCOS
still
unclear.
There
a
large
gap
precise
diagnosis
individualized
treatment.
We
summarize
present
findings
concerning
genetics,
epigenetics,
gut
microbiota,
corticolimbic
brain
responses,
metabolomics
mechanism,
highlight
remaining
challenges
phenotyping
potential
treatment
approaches,
explain
vicious
circle
intergenerational
transmission
PCOS,
which
might
provide
more
thoughts
for
better
management
future.